Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Being based in the East of Germany (the region will support Berlin, Brandenburg and Mecklenburg-Vorpommern) and reporting to the Associate Medical Director Hematology/Oncology, the Medical Science Liaison for Hematology/Oncology is responsible for the implementation of the local affiliates' Medical Plan and tactics that support the successful commercialization of in-market and future Jazz Pharma products.
APCT1_DE